Cancer Genetics (NASDAQ:CGIX) Now Covered by Analysts at started coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report issued on Tuesday. The firm issued a sell rating on the stock. Cancer Genetics Stock Performance CGIX stock opened at $0.18 on Tuesday. Cancer Genetics has a 1 year low of $2.11 and a 1 year high of $17.50. The […]

Leave a Reply

Your email address will not be published.

Previous post Kingfisher’s (KGF) “Hold” Rating Reiterated at Deutsche Bank Aktiengesellschaft
Next post Begins Coverage on LightPath Technologies (NASDAQ:LPTH)